BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2523663)

  • 1. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
    Simonsen K; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R; Svensson A; Dahlöf B; Hansson L
    Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
    Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
    Sundstedt CD; Rüegg PC; Keller A; Waite R
    Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
    Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
    Dahlöf B
    Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isradipine in essential hypertension: the Belgian General Practitioners' Study.
    De Keyser P; Bouvé J; Clement D; Degraef R; Meurant JP; Rorive G; Van Thillo J
    Am J Med; 1989 Apr; 86(4A):103-9. PubMed ID: 2565687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and hemodynamic effects of isradipine in essential hypertension.
    Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
    Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
    Nelson EB; Pool JL; Taylor AA
    Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter comparison of isradipine and prazosin for treatment of essential hypertension.
    Swartz SL; Gonasun LM; McAllister RG; Thadani U
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):413-7. PubMed ID: 2149512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.